Opiant Pharmaceuticals OPNT

$ 20.65 0.0%

Quarterly report 2022-Q3
added 11-14-2022

Opiant Pharmaceuticals Interest Expense 2011-2024 | OPNT

Annual Interest Expense Opiant Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.13 M	131 K	-	145 K	20 K	-11.9 K	28.2 K	160 K	553 K	61.4 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.13 M	-11.9 K	357 K

Quarterly Interest Expense Opiant Pharmaceuticals

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	391 K	401 K	421 K	-	547 K	542 K	537 K	-	-	-	-	-	112 K	123 K	122 K	-	20 K	6 K	5 K	877	7 K	12 K	7 K	5.49 K	-2 K	-11.3 K	-2.24 K	19.4 K	5.83 K	27.6 K	4.1 K	6.24 K	8.21 K	132 K	8.21 K	109 K	126 K	255 K	126 K	3 K	145 K	3.73 K	145 K	-	13.5 K	-	13.5 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
547 K	-11.3 K	116 K